NEW YORK, Dec. 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

US Nucleic Acid Testing Market

http://www.reportlinker.com/p0591341/US-Nucleic-Acid-Testing-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Highlights

• Comprehensive 880-page market segmentation analysis of the US NAT market.
• Major issues pertaining to the US NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
• An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
• Ten-year test volume and reagent sales forecasts for the following categories:

- Infectious Diseases

- Cancer

- Forensic Testing

- Genetic Diseases

- Paternity Testing/HLA Typing

• Review of testing methodologies and instrumentation technologies.
• Feature comparison of automated and semiautomated analyzers.
• Sales and market shares of leading suppliers.
• Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products.
• Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
• Business planning issues and concerns.

Contains 880 pages and 37 tables

Table of Contents

Introduction

Worldwide Market And Technology Overview

A. DNA Sequencing

1. Introduction

2. Sequencing Methods

3. Autoradiography

4. The Human Genome Project

5. Sequencing Automation

6. Image Scanners

7. Fluorescent Detection

8. Gene Profiling

9. Gene Expression

10. Polymorphism Screening

11. Protein Interaction Networks

B. DNA And RNA Probe Technology

1. Basic Principles

2. Probe Preparation

3. The DNA Probe Test

a. Sample Preparation

b. Hybridization

c. Separation

d. Detection/Measurement

4. Test Formats

a. Filter Hybridization

b. Southern Blot

c. Northern Blot

d. In Situ Hybridization

e. Others

5. Labeling Techniques

6. Amplification Methods Polymerase Chain Reaction

Temperature Cyclers

PCR Variations

ImmunoPCR

QCPCR

DAPPCR Strand Displacement Activation TMA Ligase Chain Reaction Branched DNA

Hybridization Protection Assay NucleicAcid SequenceBased Amplification SelfSustained Sequence Replicase Others

Ampliprobe

CAR

CAS

CPT

Dendritic Polymer Technology

ISOCR

LAT

Probe Networks

RAMP

Repair Chain Reaction

Rolling Circles

Sequence Independent Gene Amplification

Sequence Initiation Reaction

SISPA

C. Detection Technologies

1. Radioactive Methods

a. Overview

b. Major Isotopes P32 S35 H3 I125

2. NonIsotopic Methods

a. Enzymatic Labels

b. Chemical Labeling Indirect Chemical Labeling Direct Chemical Labeling

c. Fluorescence

d. Chemiluminescence

e. Electrical Conductivity

D. Instrumentation Review

1. Abbott LCx

2. Autogenomics Infinity

3. Beckman Coulter/Biomek FK

4. Becton Dickinson SDA

5. BioRad GeneScope

6. GenProbe Tigris

7. Nanosphere Verigen Series

8. Roche Cobas Amplicor

9. Tecan LS Series

E. Biochips: Genosensors, Microarrays, and

LabsontheChip

Liquid Transportation and Mixing

Separation

Reaction

Detection

F. Pharmacogenomics

G. Major Applications

1. Microbiology/Infectious Diseases

a. Overview

b. Major Infectious Diseases

AIDS Structure and Composition Classification AIDS Origins Animal Lentivirus Systems Virus Receptors HIV Infections in Humans

Pathogenesis and Pathology CD4T Lymphocytes and Memory Cells Monocytes and Macrophages Lymphoid Organs Neural Cells Viral Coinfections

Clinical Findings Plasma Viral Load

Pediatric AIDS

Neurologic Disease

Opportunistic Infections

Cancer Immunity Laboratory Diagnosis

Virus Isolation

Serology

Viral Nucleic Acid/Antigen Detection Epidemiology

Worldwide Spread of AIDS

United States

Routes of Transmission Prevention, Treatment, And Control

Antiviral Drugs

Vaccines Transmission HIV in Blood Products HIV Transmission in Transplant

and Artificial Insemination Recipients Diagnostic Tests

Enzyme Immunoassay Interpretation

Specificity, Sensitivity and Predictive

Value Competition Assays Western Blot Technique ImmunoFluorescence Assays (IFA) Radioimmunoprecipitation HIV1/HIV2 Combination Testing Methods of HIVAntigen Detection Antigen Assays and Blood Screening Urine Tests DNA Probes

Overview

Quantitative PCR

In Situ PCR

Needed Improvements Viral Load/Drug Resistance Testing Genotype and Phenotype Testing Blood Banking Considerations

Adenovirus Background Diagnostic Tests Vaccines and Drugs AdenoAssociated Viruses (AAV)

Anthrax/Bacillus Anthracis Background Diagnostic Tests Vaccines and Drugs

Babesiosis Background

BEA and Other Bartonella Diseases Background Diagnostic Tests Vaccines and Drugs

Chagas Disease Background

Campylobacter Background Diagnostic Tests

Culture Identification Vaccines and Drugs

Chlamydia Background

Chlamydia psittaci

Chlmaydia pneumoniae

Chlamydia trachomatis Diagnostic Tests Vaccines and Drugs

CreutzfeldtJakob's Disease Background Blood Transmission Diagnostic Tests Major Commercial and Academic Players

Bayer

Disease Sciences/Bio Tec Global

Imperial College School of Medicine

OrthoClinical Diagnostics

Pall

ProMetic Life Sciences

Proteome Sciences/Idexx

QOne Biotech

Serono

U.S. Agricultural Research Service Drugs Vaccines

Cytomegalovirus Background

Chorioretinitis

Gastrointestinal

Central Nervous System Disease Diagnostic Tests Vaccines and Drugs

Ebola Virus Background

Epidemiology

Clinical Syndromes Diagnostic Tests Vaccines and Drugs

EchoVirus Background

Acute Aseptic Meningitisis

Encephalitis

Exanthems

Respiratory Disease

Myopericarditis

Neonatal Infections Diagnostic Tests Vaccines and Drugs

Encephalitis Background Diagnostic Tests Vaccines and Drugs

Enteroviruses Background Diagnostic Tests

Viral Isolation and Identification

Antibody Tests Vaccines and Drugs

EpsteinBarr Virus Background Diagnostic Tests Vaccines and Drugs

Gonorrhea Background Diagnostic Tests Vaccines and Drugs

Hepatitis Hepatitis A Hepatitis B

Structure and Composition

Replication Hepatitis C Hepatitis D (Delta) Hepatitis E Hepatitis G Hepatitis Infections Pathology Clinical Findings Laboratory Tests

Hepatitis A

Hepatitis B

Hepatitis C

Hepatitis D

Hepatitis E VirusHost Immune Reactions Epidemiology

Hepatitis A

Hepatitis B

Hepatitis C

Hepatitis D (Delta) Vaccines and Drugs

Herpes Simplex Virus Background Diagnostic Tests Vaccines and Drugs

Legionella Background Diagnostic Tests Vaccines and Drugs

Lyme Disease Background

Clinical Description

Clinical Case Definition

Laboratory Criteria for Diagnosis

Case Classification Diagnostic Tests Vaccines and Drugs

Malaria

Mycoplasma Background

Ureaplasma Urealyticum & Mycoplasma

Hominis Diagnostic Tests Vaccines and Drugs

Papillomaviruses/HPV Background

HPV in Cancer

Cervical Neoplasm Diagnostic Tests Vaccines and Drugs Prevention

Parvovirus B19 Background

Microbiology

Epidemiology

Clinical Syndromes

Erythema Infectiosum (Slapped Cheek)

Adult Polyarthropathy

Transient Aplastic Crisis

Transient Pancytopenia

Red Cell Aplasia in Immunocompromised

Perinatal Infections Diagnostic Test Vaccines and Drugs

Pneumonia Background Diagnostic Tests Vaccines and Drugs

Polyomaviruses Background Diagnostic Tests Vaccines and Drugs

Salmonellosis Background Diagnostic Tests Vaccines and Drugs

Shigellosis Background Diagnostic Tests Vaccines and Drugs

Streptococci Background Diagnostic Tests Vaccines and Drugs

Group A Streptococci

Group B Streptococci

Toxoplasmosis Background Diagnostic Tests Vaccines and Drugs

Tuberculosis Background Diagnostic Tests

Microscopic Characteristics

Cultural Characteristics

Skin Tests

MDRTB Vaccines and Drugs

West Nile Virus Background

Clinical Syndromes Diagnostic Tests Vaccines and Drugs

Yersinia Background Diagnostic Tests Vaccines and Drugs

c. Antibiotic Susceptibility

2. Cancer Testing

a. Overview

b. Major Cancer Types

Prostate

Lung

Colon and Rectum

Breast

Skin

Uterine

Leukemia

Oral

c. Oncogenes Abl/ablbcr AIB1 BRCA1 CD44 Cfos Cmyb Cmyc CYP17 ErbB HPC1 Nmyc P40 P51 P53 PIK3CA PTI1 Ras Reg Sis Src

3. Genetic Diseases

a. Overview

b. Nucleic Acid Amplification

c. Chromosome Imaging

d. Genomics Technologies

e. Proteomics Technologies

f. Current Pharmacogenomic Tests

g. Future Pharmacogenomic Testing

h. Major Diseases

Achondroplasia

Autosomal Dominant Polycystic Kidney

Disease

Cancer

Cosmetogenomics

Cystic Fibrosis

Down's Syndrome

Duchenne and Becker Muscular Dystrophy

Factor V (Leiden)

Factor IX Deficiency

Fragile X Syndrome

Heart Disease

Hemochomatosis

Hemophilia

Huntington's Disease

MaternalFetal Incompatibility

Multiple Endocrine Neoplasia

Phenylketonuria (PKU)

Polycystic Kidney Disease (PKD)

Prenatal Screening

Retinitis Pigmentosa

Retinoblastoma

Sickle Cell Anemia

Spinal Muscular Atrophy

Vitamin B12 Metabolism

i. Social Issues and Concerns

4. Forensic Testing

a. Overview

b. Multilocus and Single Locus Probes

Multilocus Probes

Single Locus Probes

PCR and RFLP

c. The FBI

d. DNA Profile Data Banks

U.S.A.

U.K.

e. Judicial Implementation

f. Major Crime Categories

g. Factors Contributing to the DNA Probe

Market Expansion

Technology Availability

Use of Hair as Evidence

h. Wildlife Forensics

5. Paternity Testing/HLA Typing

6. Other Applications

a. Disease Susceptibility Testing

b. Cardiovascular Diseases

c. Diabetes

d. Alzheimer's Disease

e. Plasma Purification

f. Organ Transplantation

g. Water Contamination

h. Others

G. Cost Analysis

1. Equipment

2. Consumables

H. Competing/complementing Technologies

1. Monoclonal Antibodies/Immunoassays

2. RNA Probes

3. Two Dimensional Electrophoresis

4. Flow Cytometry

I. Reimbursement Issues

J. Worldwide Market Overview

1. Business Environment

2. Market Structure

3. Market Size and Growth

U.S.A.

A. Executive Summary

B. Business Environment

1. Health Care Expenditures

2. Cost Consciousness

3. Reimbursement

4. Industry Consolidation

5. Managed Care

a. HMO

b. PPO

6. Hospitals

7. Admissions

8. Length of Stay

9. Industry Diversification

10. Physician Demographics

11. Population Aging

a. Chronic Illness

b. Disease Incidence

c. Susceptibility to Iatrogenesis

d. Multiple Illness Cases

12. Laboratory Regulations

13. FDA Reform

C. Market Structure

1. Hospitals

2. Commercial/Private Laboratories

3. Blood Banks

D. Market Size, Growth and Major Suppliers'

Sales and Market Shares

Major Product Development Opportunities

A. Instrumentation

B. Reagent Kits and Test Systems/panels

C. Computers, Software and Automation

D. Auxiliary Products

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies For Decentralized Testing

Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types Of Distributors

7. Market Segmentation

Potential Market Entry Barriers And Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge And Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

Competitive Profiles

Abbott

Aclara

Affymetrix

Agilent

Ambion

Applera

Applied Gene Technologies

Beckman Coulter

Becton Dickinson

Biokit

BioMerieux

Biotest

Boston Biomedica

Caliper

Cepheid

Chiron

Decode

Diadexus

Digene

Eiken

Enzo

Exact Sciences

Fujirebio

GenProbe

Gene Tec

Illumina

Innogenetics

Kreatech

LiCor

Molecular Diagnostics

Myriad Genetics

Nanogen

Nuvelo

Orchid Biosciences

Qiagen

Roche

Sangtec

Sequenom

Scienion

Sierra Diagnostics

Shimadzu

Takara Bio

Tepnel Life Sciences

Tecan Group

Third Wave

Appendixes

Appendix I: Major Companies Developing or Marketing

NAT Reagents and Test Kits

Appendix II: Major Universities and Research Centers

Developing NAT Technologies

Appendix III: Glossary of Terms

Appendix IV: Currency Exchange Rates

List of Tables

Major Companies Developing or Marketing Thermocyclers

Major Companies Developing or Marketing AIDS NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Adenovirus NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Campylobacter NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Chlamydia NAT And Other Direct Identification Tests

Major Companies Developing or Marketing CMV NAT And Other Direct Identification Tests

Major Companies Developing or Marketing EBV NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Gonorrhea NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Hepatitis NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Herpes NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Legionella NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Lyme Disease NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Mycoplasma NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Papilloma Virus NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Pneumonia NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Salmonella NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Shigella NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Streptococci NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Toxoplasmosis NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Tuberculosis NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Cancer NAT Tests

Major Companies Developing or Marketing NAT Assays For Genetic Diseases

Worldwide, Laboratories Performing DNA Sequencing By Country

Worldwide, NAT Market, Potential Laboratory Universe by Country

Worldwide, NAT Volume Forecast by Country

Worldwide, NAT Market Forecast by Country

Summary Table U.S.A., NAT Volume And Sales Forecast by Major Application

U.S.A., Laboratories Performing DNA Sequencing by Market Segment

U.S.A., NAT Market, Potential Laboratory Universe by Market Segment

U.S.A., NAT Volume Forecast By Major Application

U.S.A., Major Infectious Disease NAT Volume Forecast

U.S.A., Infectious Disease Screening NAT Volume by Test Forecast

U.S.A., NAT Market Forecast By Major Application

U.S.A., Infectious Disease Screening NAT Reagent Market Forecast by Test

U.S.A., NAT Market by Major Supplier

U.S.A., HIV/Hepatitis C NAT Market By Major Supplier

U.S.A., West Nile Virus NAT Market By Major Supplier

To order this report:

: US Nucleic Acid Testing Market

More  Market Research Report

Check our  Real Time Industry Data

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Back to top

RELATED LINKS
http://www.reportlinker.com